- 29 June 2019
- 3 min read
Widespread HPV vaccination programmes ‘could eliminate cervical cancer’
SubscribeThe HPV vaccination treatment was linked to a huge reduction in the two types of HPV – 16 and 18.

Cervical cancer could be eliminated by widespread HPV vaccination programmes, according to scientists who reviewed studies of 60 million people in affluent countries.
The treatment was linked to a huge reduction in the two types of HPV – 16 and 18 – which cause 70% of cervical cancers, research found.
Read more
• Vaccinating boys against HPV may reduce cancer rates, study indicates
Rates of both types of HPV in high-income countries, among girls aged 13 to 19, plummeted by up to 83% following five to eight years of vaccination, while a reduction of 66% was found in women aged 20 to 24.

Decreases seen in other conditions too
A significant decrease was also seen in anogenital wart diagnoses and precancerous cervical lesions which can develop into cancer.
Professor Marc Brisson, a member of the research team, said: “Because of our finding, we believe the World Health Organisation (WHO) call for action to eliminate cervical cancer may be possible in many countries if sufficient vaccination coverage can be achieved.”
The researchers, whose work was published in The Lancet journal, analysed 65 studies from 14 high-income countries.
Declines in the HPV “endpoints” were found eight to nine years after girls-only vaccination.
The findings support the recently revised WHO position on vaccinating multiple age groups, rather than a single cohort, when introducing the vaccine.
The NHS currently offers the first dose of the HPV vaccine to girls aged 12 and 13, with a second six to 12 months later.

Earlier analysis of studies for four years post-vaccination has also shown substantial decreases in HPV 16 and 18.
The studies looked at for the new research compared levels of one or more HPV endpoints across pre and post-vaccination periods.
Reductions of HPV seen in multiple areas
An overall 54% reduction was also found in three other types of HPV – 31, 33 and 45 – in girls aged 13 to 19.
Meanwhile, a decrease in anogenital warts of 67% was seen in girls aged 15 to 19, 54% in women aged 20 to 24 and 31% in those aged 25 to 29.
Reductions of 48% were found in boys aged 15 to 19 and 32% in men aged 20 to 24 years.
Five to nine years after vaccination, precancerous cervical lesions decreased by 51% in screened girls aged 15 to 19 and by 31% in women aged 20 to 24.
Co-researcher Melanie Drolet, from the CHU de Quebec-Laval University Research Centre, said: “Our results provide strong evidence that HPV vaccination works to prevent cervical cancer in real-world settings, as both HPV infections that cause most cervical cancers and precancerous cervical lesions are decreasing.”
She said the research “reinforces WHO’s recently revised position on HPV vaccination”.
About this contributor
Nurses.co.uk editorial team
Bringing you a daily update of nursing, NHS, health and social care news from around the UK.
More by this contributorWant to get involved in the discussion?
Log In Subscribe to comment